GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRB1, AKR1B1, APP, AR, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MAOA, MET, MIF, PPARA, PRKCD, PTGS1, PTGS2, SLC1A1, SMAD3, SRC, TEK, XDH |
11.4866 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EGFR, ERBB2, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, MET, MIF, PPARA, PTGES, PTGS1, PTGS2 |
10.5282 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APP, AR, AXL, CA2, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, NR3C1, PPARA, PRKCD, PTGES, PTGS2, SMAD3, SRC, TEK, TYR |
10.1342 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AR, AXL, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, GRIK5, GRM5, HSD17B2, IGF1R, INSR, MMP2, MMP9, NR3C1, PPARA, PRKCD, PTGES, PTGS2, SRC, TEK, TYR |
10.1342 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, AR, CSNK2A1, CXCL8, CYP1B1, EGFR, ERBB2, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NUAK1, PGR, PIM1, PTGES, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH |
10.1342 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRB1, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, F3, FLT3, GPR35, GRM1, HCAR2, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
10.1227 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRB1, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, F3, FLT3, GPR35, GRM1, HCAR2, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
10.1227 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRB1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DUSP3, EGFR, ERBB2, F3, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
9.61397 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGES, PTGS1, PTGS2 |
9.60609 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRB1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DUSP3, EGFR, ERBB2, F3, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
9.50885 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, AR, CA2, CA9, CSNK2A1, CXCL8, CYP1A2, EGFR, ERBB2, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, NR3C1, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK |
9.43198 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGES, PTGS1, PTGS2 |
9.36954 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
9.27097 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGES, PTGS1, PTGS2 |
9.08016 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APP, AR, AXL, CA2, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, PPARA, PRKCD, PTGES, PTGS2, SMAD3, SRC, TEK, TYR |
8.81536 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.21069 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, EGFR, ERBB2, F3, FLT3, GPR35, GRM1, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
8.1523 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, APP, AR, AXL, CYP1B1, EGFR, ERBB2, F3, FLT3, GPR35, GRM1, HSPA1A, INSR, KDR, MET, MIF, PTGS2, SRC, TEK, XDH |
7.96102 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ERBB2, F3, FLT3, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP9, NUAK1, PRKCD, PTGS2, SRC, TEK, XDH |
7.93557 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, FUT7, HSPA1A, MIF, PIM1, PPARA, PTGES, PTGS1, PTGS2, TYR, XDH |
7.80784 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGES, PTGS1, PTGS2 |
7.80784 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AR, AXL, CXCL8, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP4, FLT3, GRIK5, GRM5, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, PRKCD, PTGS2, SMAD3, SRC |
7.67732 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, AR, AXL, CA2, CA7, CACNA1C, CSNK2A1, CXCL8, CYP19A1, CYP1B1, EGFR, ERBB2, F3, GPR35, GRIK5, GRM5, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK |
7.58667 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EGFR, ERBB2, FABP3, FABP4, FUT7, MET, MIF, PPARA, PTGES, PTGS1, PTGS2 |
7.31038 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PPARA, PTGES, PTGS1, PTGS2 |
7.14841 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AR, AXL, CXCL8, CYP1A1, CYP1B1, EGFR, ERBB2, FABP4, FLT3, GRIK5, GRM5, IGF1R, INSR, KDR, MMP2, NR3C1, PRKCD, PTGS2, SMAD3, SRC |
7.11515 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, CACNA1C, CXCL8, CYP19A1, CYP1B1, EGFR, ERBB2, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
7.08315 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, MET, PRKCD, SRC, TEK |
7.08315 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRB1, APP, AR, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
7.05181 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, CXCL8, EGFR, ERBB2, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, MIF, MMP2, MMP9, PRKCD, SMAD3, SRC, TEK |
7.04969 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, MET, PRKCD, SRC, TEK |
7.03793 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGES, PTGS1, PTGS2 |
7.03755 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, APP, AR, AXL, CSNK2A1, CXCL8, CYP1B1, EGFR, ERBB2, F3, FABP4, FLT3, GPR35, GRM1, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
7.02013 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRB1, APP, AR, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
7.02013 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, HSD11B1, HSD17B1, HSD17B2 |
7.01828 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, CA2, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, HSD17B2, NR3C1, PTGES, PTGS2, SRC, TYR |
6.93943 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.93943 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, PRKCD, PTGES, PTGS2, SRC |
6.93943 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GRIK5, HCAR2, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
6.93943 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, CXCL8, CYP19A1, CYP1B1, EGFR, ERBB2, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
6.9348 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRB1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ERBB2, F3, FABP3, FLT3, GPR35, GRIK5, GRM1, GRM5, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
6.92654 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GRIK5, HCAR2, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
6.90756 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.86591 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK |
6.7657 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, AR, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, INSR, NR3C1, PPARA, PRKCD, PTGS2, SRC, TEK |
6.71242 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CACNA1C, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, FLT3, HSD11B1, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR |
6.71056 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PRKCD, PTGS2, SMAD3, SRC, TEK |
6.60511 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, CXCL8, CYP19A1, CYP1B1, EGFR, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
6.56672 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRB1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIM1, PPARA, PRKCD, PTGS2, SLC1A1, SMAD3, SRC, TEK, XDH |
6.52383 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AR, AURKB, AXL, CA2, CA9, CXCL8, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP4, FLT3, GRIK5, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MIF, MMP2, MMP9, NR3C1, NUAK1, PRKCD, PTGS2, SMAD3, SRC |
6.49544 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, CXCL8, CYP19A1, CYP1B1, EGFR, ERBB2, F3, IGF1R, INSR, KDR, MET, MIF, MMP9, PTGS2, SMAD3, SRC, TEK |
6.45717 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRB1, AKR1B1, APP, AR, AXL, CA1, CA2, CACNA1C, CSNK2A1, CXCL8, CYP1B1, EGFR, ERBB2, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, MIF, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCD, PTGES, SMAD3, SRC, TEK |
6.37847 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GRIK5, HCAR2, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
6.33177 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
6.22636 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
6.22636 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, AR, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FLT3, NR3C1, PTGES, PTGS2, SRC, TEK, TYR |
6.16936 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALPL, APP, AR, AURKB, AXL, CA2, CA9, CSNK2A1, CXCL8, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NR3C1, NUAK1, PPARA, PRKCD, PTGES, PTGS1, PTGS2, SMAD3, SRC, TEK, TYR |
6.13694 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, EGFR, GRM1, GRM3, GRM5, GRM8, PTGS2 |
6.06173 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AXL, CACNA1C, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, F3, FABP4, GRM1, GRM5, GRM8, HSD17B2, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, TYR |
6.01534 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, PRKCD, PTGS2, SMAD3, SRC, TEK |
5.96767 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CXCL8, CYP1B1, EGFR, GRIK5, GRM5, IGF1R, INSR, MMP2, MMP9, NR3C1, PRKCD, PTGS2, SRC |
5.95565 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.86568 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DUSP3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCD, PTGES, PTGS1, PTGS2, SMAD3, SRC, TEK, TYR, XDH |
5.84322 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRB1, APP, AR, EGFR, ERBB2, FABP3, FLT3, GRM1, GRM5, INSR, KDR, MIF, MMP9, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
5.83105 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRB1, APP, AR, EGFR, ERBB2, FABP3, FLT3, GRM1, GRM5, INSR, KDR, MIF, MMP9, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
5.83105 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRB1, APP, AR, AURKB, CSNK2A1, CXCL8, CYP1B1, CYP2D6, DUSP3, EGFR, ERBB2, F3, FABP4, FLT3, GPR35, GRM1, GRM3, GRM5, HSPA1A, IGF1R, INSR, MET, MIF, MMP9, NUAK1, PIM1, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
5.77991 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.74474 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.74474 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, AR, CXCL8, EGFR, ERBB2, FLT3, GRM5, IGF1R, INSR, MMP2, NR3C1, PRKCD, PTGS2, SMAD3, SRC |
5.74474 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B1, HSD17B1, HSD17B2, MAOA, PTGS1, PTGS2, TYR, XDH |
5.70539 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, AR, DUSP3, EGFR, ERBB2, FLT3, GRM1, IGF1R, INSR, KDR, MIF, PRKCD, SRC, TEK, XDH |
5.4537 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.44519 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, CXCL8, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
5.44078 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRB1, APP, AR, AURKB, CSNK2A1, DUSP3, EGFR, ERBB2, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HSPA1A, IGF1R, INSR, MIF, MMP9, NUAK1, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
5.40585 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, CXCL8, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
5.28029 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.24445 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, CXCL8, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
5.16153 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRB1, APP, AR, AXL, CA2, CACNA1C, CXCL8, CYP1B1, EGFR, ERBB2, F3, GPR35, GRM1, HCAR2, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PIM1, PRKCD, PTGS2, SLC1A1, SMAD3, SRC, TEK, XDH |
5.16153 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRB1, AKR1B1, APP, AXL, CA12, CA2, CA7, CACNA1C, EGFR, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3, SRC |
5.11649 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PPARA, PTGES, PTGS1, PTGS2 |
5.08833 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, CSNK2A1, EGFR, ERBB2, F3, FLT3, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PTGS2, TEK |
5.05794 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, CXCL8, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
5.01292 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CXCL8, CYP1B1, DUSP3, EGFR, ERBB2, F3, FLT3, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
5.01246 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALPL, APP, AR, AURKB, AXL, CA2, CA9, CACNA1C, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ERBB2, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, INSR, KDR, MET, MIF, MMP2, MMP9, PGR, PIM1, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, TYR |
4.97007 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRB1, APP, AR, AXL, CA2, CXCL8, CYP1B1, EGFR, F3, HCAR2, HSPA1A, KDR, MET, MIF, MMP12, MMP9, PIM1, PTGS2, SLC1A1, SMAD3, SRC, TEK |
4.94705 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, ERBB2, FLT3, GRM1, IGF1R, INSR, MIF, PRKCD, SRC |
4.80959 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, AR, EGFR, ERBB2, FLT3, GRM1, INSR, KDR, MIF, SRC, TEK, XDH |
4.80923 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CA7, CACNA1C, CYP19A1, EGFR, ERBB2, GPR35, GRIK5, GRM5, HCAR2, HSPA1A, INSR, MIF, MMP12, MMP9, PPARA, PRKCD, PTGS2, SMAD3, SRC |
4.79006 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, PRKCD, PTGS1, PTGS2, SRC |
4.78144 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GRM5, IGF1R, INSR, PPARA, PRKCD, PTGS2, SRC, TEK |
4.7089 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, AR, EGFR, ERBB2, FLT3, GRM1, GRM5, INSR, KDR, MIF, MMP9, PRKCD, PTGS2, SRC, TEK, XDH |
4.68904 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, DUSP3, EGFR, F3, FABP4, HSPA1A, IGF1R, MET, MIF, MMP12, MMP2, NUAK1, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
4.65431 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, F3, INSR, MET, SRC, TEK, XDH |
4.63561 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AR, AXL, CA2, CACNA1C, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ERBB2, FLT3, HSD11B1, HSD17B2, INSR, KDR, MMP9, PGR, PIM1, PPARA, PTGS2, SMAD3, SRC, TEK, TYR |
4.63561 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, F3, INSR, MET, SRC, TEK |
4.62318 |
[BP] GO:0001516 |
None
|
MIF, PTGES, PTGS1, PTGS2 |
4.60805 |
[BP] GO:0046457 |
None
|
MIF, PTGES, PTGS1, PTGS2 |
4.60805 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, AR, DUSP3, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, KDR, MIF, MMP9, PPARA, PRKCD, PTGS2, SRC, TEK, XDH |
4.47269 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.47269 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, PRKCD, SRC |
4.45899 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, AR, EGFR, ERBB2, FLT3, GRM1, GRM5, INSR, KDR, MIF, MMP9, PRKCD, PTGS2, SRC, TEK, XDH |
4.457 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, EGFR, ERBB2, FLT3, MET, MIF, PIM1, PRKCD, SRC, TEK, TYR |
4.457 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, PPARA, PRKCD, PTGS2, SRC, TEK, TYR |
4.457 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, AR, DUSP3, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, KDR, MIF, MMP9, PRKCD, PTGS2, SRC, TEK, XDH |
4.42777 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CXCL8, CYP19A1, CYP1B1, CYP2D6, DUSP3, EGFR, ERBB2, FABP3, FABP4, GPR35, GRM3, GRM8, HCAR2, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PIM1, PPARA, PRKCD, PTGES, PTGS2, SMAD3, SRC, TEK, XDH |
4.39453 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, ADRB1, AKR1B1, APP, AURKB, CA2, CYP1A1, EGFR, GRM1, HSPA1A, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK, TYR |
4.38291 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CXCL8, CYP19A1, CYP1B1, DUSP3, EGFR, ERBB2, F3, FABP4, FLT3, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, NUAK1, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
4.35654 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX5, MIF, PTGES, PTGS1, PTGS2 |
4.31914 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CXCL8, CYP19A1, EGFR, F3, FABP4, KDR, MET, MIF, MMP12, PPARA, PRKCD, PTGS2, SMAD3, TEK |
4.30981 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOA, MET, MIF, MMP1, MMP2, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCD, PTGES, PTGS1, PTGS2, SMAD3, SRC, TEK, TYR, XDH |
4.26578 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, CXCL8, DUSP3, EGFR, ERBB2, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PRKCD, PTGS2, SMAD3, SRC, XDH |
4.25513 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, CXCL8, DUSP3, EGFR, ERBB2, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PRKCD, PTGS2, SMAD3, SRC, XDH |
4.23734 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DUSP3, FABP4, GPR35, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PRKCD, PTGS2, SRC |
4.18496 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, CXCL8, EGFR, ERBB2, INSR, KDR, NR3C1, SMAD3, SRC |
4.15431 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SRC, TEK |
4.12646 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PRKCD, PTGS2, SRC, TEK |
4.12308 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
4.08652 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, PPARA, PRKCD, PTGS2, SRC, TEK, TYR |
4.07771 |
[BP] GO:0050678 |
None
|
AR, EGFR, ERBB2, F3, KDR, MMP12, PGR, SMAD3, TEK, XDH |
4.05446 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD11B1, HSD17B1, HSD17B2 |
4.05446 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, HCAR2, HSD11B1, HSD17B1, HSD17B2 |
4.05446 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, CA12, CA2, CA7, CACNA1C, EGFR, FABP3, FABP4, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3 |
4.05382 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, EGFR, GRIK5, INSR, MAOA, PTGS2, SLC1A1, SMAD3 |
4.03616 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, PRKCD, SRC, TEK |
4.0329 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, AR, CSNK2A1, EGFR, ERBB2, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, KDR, MIF, MMP9, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
4.02436 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, AR, DUSP3, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PRKCD, PTGS2, SRC, TEK, XDH |
4.0124 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, AR, CXCL8, CYP19A1, DUSP3, EGFR, ERBB2, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
3.98231 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5, MIF, PRKCD |
3.969 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CYP19A1, EGFR, ERBB2, HCAR2, INSR, MIF, MMP12, PRKCD, PTGS2, SMAD3, SRC |
3.9594 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRB1, APP, AR, AURKB, CSNK2A1, EGFR, ERBB2, F3, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
3.9594 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CXCL8, CYP19A1, CYP1B1, CYP2D6, DUSP3, EGFR, ERBB2, FABP3, FABP4, GPR35, GRM3, GRM8, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PIM1, PPARA, PRKCD, PTGES, PTGS2, SMAD3, SRC, TEK, XDH |
3.95098 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, DUSP3, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, MIF, PRKCD, SRC, TEK |
3.93422 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, PRKCD, SRC |
3.93084 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CACNA1C, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DUSP3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCD, PTGES, PTGS1, PTGS2, SLC1A1, SMAD3, SRC, TEK, XDH |
3.88553 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGES, PTGS1, PTGS2, TYR |
3.88063 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.86861 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, AR, CYP1A1, CYP1B1, EGFR, FLT3, NR3C1, PTGS2, SRC |
3.86133 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, AR, EGFR, ERBB2, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, KDR, MIF, MMP9, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
3.80966 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, HSPA1A, MAOA, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.79119 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CACNA1C, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DUSP3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCD, PTGES, PTGS1, PTGS2, SLC1A1, SMAD3, SRC, TEK, TYR, XDH |
3.77561 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, PRKCD, PTGS2, SMAD3, XDH |
3.76422 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CXCL8, EGFR, F3, FABP4, KDR, MET, MIF, PTGS2, SMAD3 |
3.76394 |
[BP] GO:0070848 |
response to growth factor
|
APP, CXCL8, EGFR, ERBB2, INSR, KDR, NR3C1, SMAD3, SRC |
3.76394 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, HCAR2, PPARA, PRKCD, PTGS2, SRC, TEK |
3.74636 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD17B1, HSD17B2, MIF, PTGES, PTGS1, PTGS2 |
3.73921 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, EGFR, KDR, NR3C1, PRKCD, PTGS2, SRC |
3.73257 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, DUSP3, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, MIF, PRKCD, SRC, TEK |
3.70513 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRB1, APP, AR, AURKB, EGFR, ERBB2, F3, FABP3, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
3.66409 |
[BP] GO:0008217 |
None
|
ADORA1, ADRB1, AR, PPARA, PTGS1, PTGS2, SMAD3 |
3.64947 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK |
3.63012 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, DUSP3, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, MIF, PRKCD, SRC |
3.61586 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.60674 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, CA2, EGFR, FLT3, NR3C1, PTGS2, SRC |
3.58566 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, CACNA1C, EGFR, HCAR2, KDR, MIF, PTGS2, SRC |
3.57661 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRB1, APP, AR, AURKB, EGFR, ERBB2, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, MET, MIF, MMP9, PRKCD, SMAD3, SRC, TEK, XDH |
3.57661 |
[BP] GO:0050927 |
None
|
CXCL8, F3, KDR, SMAD3 |
3.54331 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, EGFR, ERBB2, HCAR2, MIF, MMP12, PRKCD, PTGS2, SMAD3, SRC |
3.53217 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.50187 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, CACNA1C, EGFR, ERBB2, HCAR2, MIF, MMP12, PRKCD, PTGS2, SMAD3, SRC |
3.49063 |
[BP] GO:0050926 |
None
|
CXCL8, F3, KDR, SMAD3 |
3.48699 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.48699 |
[BP] GO:0006693 |
None
|
MIF, PTGES, PTGS1, PTGS2 |
3.48699 |
[BP] GO:0006692 |
None
|
MIF, PTGES, PTGS1, PTGS2 |
3.48699 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, EGFR, GRM5, IGF1R, INSR, MMP2, PRKCD, PTGS2, SRC |
3.46688 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, CXCL8, CYP1B1, ERBB2, FABP3, HSPA1A, PTGES, PTGS2, SMAD3, XDH |
3.46621 |
[BP] GO:0050730 |
None
|
ADORA1, APP, EGFR, FLT3, GRM5, MIF, PRKCD, SRC |
3.44575 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRB1, APP, AR, AURKB, CSNK2A1, EGFR, ERBB2, F3, FABP3, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
3.44035 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, APP, AXL, CA2, CA9, CXCL8, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, HSPA1A, MIF, MMP2, MMP9, NUAK1, PPARA, PRKCD, PTGES, PTGS1, PTGS2, SMAD3, SRC, TEK |
3.43819 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, AR, EGFR, ERBB2, FLT3, GRM1, GRM5, INSR, KDR, MIF, MMP9, PRKCD, PTGS2, SRC, TEK, XDH |
3.43539 |
[BP] GO:0042391 |
None
|
ADORA1, APP, CACNA1C, GPR35, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
3.43361 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGES, PTGS1, PTGS2, TYR |
3.43361 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR |
3.39799 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CSNK2A1, DUSP3, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCD, PTGS2, SRC, TEK, XDH |
3.39003 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
3.38815 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, ERBB2, FLT3, GRM1, IGF1R, INSR, MIF, PRKCD, SRC |
3.38738 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.38241 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGES, PTGS2 |
3.36643 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGES, PTGS1, PTGS2, TYR |
3.35711 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, EGFR, INSR, PRKCD, PTGS2, SMAD3, XDH |
3.35711 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGES, PTGS2, SRC |
3.34119 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
MIF, PTGES, PTGS1, PTGS2 |
3.3318 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, MMP12, PPARA, PRKCD, SMAD3, TEK |
3.32914 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, EGFR, ERBB2, HCAR2, MIF, MMP12, PRKCD, PTGS2, SMAD3, SRC |
3.30726 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
3.29311 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, PRKCD, SRC |
3.28505 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRB1, CACNA1C, EGFR, GPR35, GRM1, HCAR2, PTGS2, SLC1A1, SMAD3 |
3.28099 |
[BP] GO:0050679 |
None
|
AR, EGFR, ERBB2, F3, KDR, MMP12, TEK |
3.27241 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, PTGS1 |
3.27104 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, PRKCD, SMAD3, TEK |
3.25096 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, EGFR, NR3C1, SRC |
3.22944 |
[BP] GO:0007154 |
None
|
ADORA1, ADRB1, AR, AXL, CACNA1C, GRIA2, GRIK5, GRM1, GRM3, GRM5, PGR, PTGS2, SLC1A1, TEK |
3.22321 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, EGFR, HSPA1A, MAOA |
3.22321 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, EGFR, GRM5, IGF1R, INSR, MMP2, PRKCD, PTGS2, SRC |
3.22321 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, EGFR, ERBB2, PPARA, SMAD3 |
3.22321 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.21323 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.21323 |
[BP] GO:0050920 |
regulation of chemotaxis
|
CXCL8, CYP19A1, F3, KDR, MET, MIF, SMAD3 |
3.18235 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRB1, APP, AURKB, EGFR, ERBB2, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, MIF, PRKCD, SMAD3, SRC, TEK, XDH |
3.17093 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, CYP2D6, MET, MMP9, PPARA, PRKCD, SMAD3, SRC |
3.15829 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AURKB, AXL, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DUSP3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCD, PTGES, PTGS1, PTGS2, SMAD3, SRC, TEK, TYR, XDH |
3.15772 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
3.15772 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, EGFR, PTGS2 |
3.15384 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CSNK2A1, DUSP3, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCD, PTGS2, SRC, TEK, XDH |
3.13512 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
3.13115 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AR, AURKB, CSNK2A1, EGFR, ERBB2, F3, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
3.12468 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, INSR, MIF, SRC |
3.11077 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, GRM5, INSR, MIF, PRKCD, SRC, TEK |
3.1086 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, PRKCD, SRC, TEK |
3.1086 |
[BP] GO:0019371 |
None
|
PTGES, PTGS1, PTGS2 |
3.1086 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR |
3.09447 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
3.09447 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
3.08661 |
[BP] GO:0071383 |
None
|
AR, EGFR, FLT3, NR3C1, SRC |
3.05853 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, FABP4, HSPA1A, MMP12, MMP2, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK |
3.03948 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
APP, DUSP3, EGFR, ERBB2, KDR, MIF, SRC, TEK |
3.01197 |
[BP] GO:0007193 |
None
|
ADORA1, GRM1, GRM3, GRM5, GRM8 |
3.01197 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
3.01197 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, PRKCD, PTGS2, SMAD3, SRC |
3.01197 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, NR3C1, NR3C2, PGR, PPARA, SRC |
3.01197 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
AR, CXCL8, DUSP3, EGFR, ERBB2, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PRKCD, PTGS2, SMAD3, SRC, XDH |
3.01197 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
2.99302 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AR, AURKB, CSNK2A1, CYP2D6, DUSP3, EGFR, FABP4, GRM3, GRM8, HCAR2, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PRKCD, PTGS2, SMAD3, SRC, XDH |
2.99302 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CXCL8, CYP1A1, CYP1A2, PTGES, PTGS2, SRC |
2.99302 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DUSP3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCD, PTGES, PTGS1, PTGS2, SMAD3, SRC, TEK, TYR, XDH |
2.98652 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, EGFR, ERBB2, FLT3, GRM1, GRM5, INSR, MIF, PRKCD, SRC, TEK |
2.96343 |
[BP] GO:1901570 |
None
|
ALOX5, MIF, PTGES, PTGS1, PTGS2 |
2.92086 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, PRKCD, SRC |
2.91451 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.91157 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.90536 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, EGFR, NR3C1, SRC |
2.90353 |
[BP] GO:0023052 |
None
|
ADORA1, ADRB1, AR, CACNA1C, GRIA2, GRIK5, GRM1, GRM3, GRM5, PGR, SLC1A1, TEK |
2.89751 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRB1, APP, AR, AURKB, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DUSP3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
2.8842 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APP, GRM5, IGF1R, INSR, PRKCD, SRC |
2.8842 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, PTGS2, TYR |
2.88344 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
2.86269 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.83526 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.83526 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRB1, AKR1B1, AXL, CACNA1C, CXCL8, CYP1B1, EGFR, ERBB2, GRM5, IGF1R, INSR, KDR, MET, MIF, NUAK1, PRKCD, SRC, TEK |
2.83032 |
[BP] GO:0016477 |
cell migration
|
AXL, CXCL8, CYP1B1, EGFR, FUT7, KDR, MIF, MMP1, MMP12, MMP9, PRKCD, SRC, TEK |
2.81829 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, FABP4, PPARA, PRKCD, PTGS2, SMAD3, TEK |
2.81829 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CXCL8, CYP1A1, CYP1A2, PTGES, PTGS2, SRC |
2.81829 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, CA2, CA7, CACNA1C, GPR35, GRM5, MIF, MMP9, PRKCD, PTGS2 |
2.74945 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.73786 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CYP1A1, CYP1B1, EGFR, FABP3, KDR, NR3C1, PRKCD, PTGS2, SRC |
2.6927 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, APP, AR, CSNK2A1, DUSP3, EGFR, ERBB2, F3, FABP4, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
2.65164 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CXCL8, CYP1B1, F3, KDR, PTGS2, TEK |
2.64637 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, GRM5, INSR, MIF, PRKCD, SRC |
2.64637 |
[BP] GO:0007267 |
None
|
ADORA1, ADRB1, AR, GRIA2, GRIK5, GRM1, GRM3, GRM5, PGR, SLC1A1, TEK |
2.64351 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, EGFR, FLT3, NR3C1, PTGS2, SRC |
2.63604 |
[BP] GO:0003018 |
None
|
ADORA1, ADRB1, EGFR, PTGS2, SRC, TEK |
2.63604 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DUSP3, HSPA1A, IGF1R, MET, MIF, MMP9, PRKCD, PTGS2, SRC, XDH |
2.63051 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, APP, AR, AURKB, AXL, CA1, CA2, CA7, CA9, CACNA1C, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DUSP3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCD, PTGES, PTGS1, PTGS2, SLC1A1, SMAD3, SRC, TEK, XDH |
2.62449 |
[BP] GO:0007188 |
None
|
ADORA1, ADRB1, GRM1, GRM3, GRM5, GRM8 |
2.62449 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRB1, APP, AR, AURKB, CA9, CSNK2A1, CYP1A1, CYP1B1, DUSP3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
2.61567 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, MET, PRKCD, SRC, TEK |
2.61567 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
HSPA1A, MIF, MMP9, PTGS2, SRC |
2.60751 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, APP, AR, AURKB, AXL, CA1, CA2, CA7, CA9, CACNA1C, CSNK2A1, CXCL8, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DUSP3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCD, PTGES, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH |
2.59243 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.571 |
[BP] GO:0040011 |
locomotion
|
AXL, CXCL8, CYP1B1, EGFR, FUT7, KDR, MET, MIF, MMP1, MMP12, MMP9, PRKCD, SRC, TEK |
2.55495 |
[BP] GO:0042307 |
positive regulation of protein import into nucleus
|
APP, EGFR, PRKCD, PTGS2, SMAD3 |
2.54792 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, APP, AR, CACNA1C, CSNK2A1, EGFR, ERBB2, HCAR2, MIF, MMP12, PRKCD, PTGS2, SMAD3, SRC |
2.53923 |
[BP] GO:1901184 |
None
|
ADORA1, APP, EGFR, ERBB2, MMP9 |
2.53075 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AR, AURKB, AXL, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PRKCD, SMAD3, SRC, TEK |
2.52571 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, EGFR, HSPA1A, IGF1R, MET, MIF, NUAK1, PRKCD, PTGS2, XDH |
2.52571 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.52571 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.52571 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.52571 |
[BP] GO:0002520 |
None
|
CACNA1C, SMAD3 |
2.52571 |
[BP] GO:1904591 |
positive regulation of protein import
|
APP, EGFR, PRKCD, PTGS2, SMAD3 |
2.52162 |
[BP] GO:0000904 |
cell morphogenesis involved in differentiation
|
AR, AXL, MET, SRC, TEK |
2.52162 |
[BP] GO:0048732 |
gland development
|
AR, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.52162 |
[BP] GO:1901342 |
regulation of vasculature development
|
CXCL8, CYP1B1, ERBB2, F3, KDR, PTGS2, TEK, XDH |
2.52076 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.50855 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.50855 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.50855 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.50855 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, NR3C1, NR3C2, PGR, PPARA, SRC |
2.49317 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.48458 |
[BP] GO:0050994 |
None
|
ADORA1, HCAR2, PPARA, PRKCD |
2.48458 |
[BP] GO:0051223 |
None
|
ACHE, APP, CACNA1C, EGFR, ERBB2, HCAR2, MIF, MMP12, PRKCD, PTGS2, SMAD3, SRC |
2.48249 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
2.4797 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB1, APP, AR, AURKB, EGFR, ERBB2, FABP3, IGF1R, INSR, KDR, MET, MMP12, NR3C1, PGR, PPARA, PRKCD, PTGS2, SMAD3, SRC |
2.45986 |
[BP] GO:0048870 |
cell motility
|
AXL, CXCL8, CYP1B1, EGFR, FUT7, KDR, MIF, MMP1, MMP12, MMP9, PRKCD, SRC, TEK |
2.45865 |
[BP] GO:0050801 |
ion homeostasis
|
APP, CA12, CA2, CA7, CACNA1C, EGFR, FABP3, GPR35, GRM1, GRM5, SMAD3 |
2.43756 |
[BP] GO:0030155 |
regulation of cell adhesion
|
CXCL8, CYP1B1, DUSP3, ERBB2, KDR, NUAK1, PPARA, PRKCD, SMAD3, SRC, TEK |
2.43756 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.4368 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.43573 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.43573 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
ADRB1, MMP1, MMP12, MMP2, MMP9 |
2.42924 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRB1, APP, AR, AURKB, CA9, CSNK2A1, CYP1B1, CYP2D6, DUSP3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
2.42097 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, EGFR, HCAR2, MIF, MMP12, SRC |
2.40812 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CXCL8, CYP1B1, F3, KDR, PTGS2, TEK |
2.40599 |
[BP] GO:0035295 |
tube development
|
AKR1B1, AR, CXCL8, CYP1A1, EGFR, SMAD3 |
2.40599 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, NR3C1, PGR, PIM1, PPARA, SRC |
2.40599 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, PRKCD, SRC |
2.39772 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, INSR, MIF, SRC |
2.37781 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.35878 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.35735 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.35735 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, APP, AR, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DUSP3, EGFR, ERBB2, F3, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, TYR, XDH |
2.34707 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
APP, AXL, CXCL8, CYP1B1, EGFR, ERBB2, FUT7, KDR, MIF, MMP1, MMP12, MMP9, PRKCD, PTGS2, SRC, TEK |
2.32431 |
[BP] GO:0019722 |
calcium-mediated signaling
|
CACNA1C, CXCL8, EGFR, GRM5, KDR |
2.31367 |
[BP] GO:0007187 |
None
|
ADORA1, ADRB1, GRM1, GRM3, GRM5, GRM8 |
2.31039 |
[BP] GO:0070201 |
None
|
ACHE, APP, CACNA1C, EGFR, ERBB2, HCAR2, MIF, MMP12, PRKCD, PTGS2, SMAD3, SRC |
2.30067 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP2D6, MAOA |
2.30015 |
[BP] GO:0001503 |
ossification
|
ALPL, EGFR, MMP2, MMP9, TEK |
2.30015 |
[BP] GO:0001775 |
cell activation
|
ALOX5, APP, AXL, CXCL8, EGFR, FLT3, FUT7, HSPA1A, MIF, MMP9, PRKCD, SMAD3, SRC |
2.2952 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.28525 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.28525 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.27951 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, PRKCD |
2.25883 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.25761 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CYP1A1, DUSP3, EGFR, INSR, MIF, SRC |
2.23481 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, PRKCD |
2.21171 |
[BP] GO:0043434 |
None
|
FABP3, INSR, PPARA, PRKCD, PTGS2, SRC, TEK |
2.21086 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.21086 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.21086 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, MIF, PPARA, PRKCD, SMAD3, TEK |
2.2043 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, CYP19A1, EGFR, HSD17B2, INSR, PGR, PTGS2, SRC |
2.19235 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, CA2, CA9, EGFR, MET, SMAD3, SRC |
2.17878 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
AR, HSPA1A, MIF, MMP9, PRKCD, PTGS2, SMAD3, SRC |
2.16861 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.16861 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
APP, EGFR, KDR, MIF, SRC, TEK |
2.16591 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, EGFR, HCAR2, MIF, MMP12, SRC |
2.1638 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRB1, CACNA1C, EGFR, PTGS2, SLC1A1 |
2.15574 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
CYP1B1, F3, GRIK5, HCAR2, MMP9, PRKCD, PTGS2, SMAD3, SRC, XDH |
2.15398 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, APP, AR, CSNK2A1, DUSP3, EGFR, ERBB2, F3, FABP4, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
2.13207 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
2.12932 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
CYP1B1, F3, GRIK5, HCAR2, MMP9, PRKCD, PTGS2, SMAD3, SRC, XDH |
2.12348 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.12074 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
ADRB1, APP, AR, AURKB, EGFR, ERBB2, FABP3, IGF1R, INSR, MET, MMP12, NR3C1, PGR, PPARA, PRKCD, PTGS2, SMAD3, SRC |
2.10258 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
2.10146 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ADRB1, ALPL, APP, AR, AXL, CYP1A1, EGFR, ERBB2, FABP4, FLT3, FUT7, KDR, MET, MIF, MMP2, MMP9, PGR, PRKCD, PTGS2, SMAD3, SRC, TEK |
2.1006 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.09936 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRB1, APP, AR, AURKB, CA9, CSNK2A1, CYP1B1, DUSP3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK, XDH |
2.09293 |
[BP] GO:0050921 |
positive regulation of chemotaxis
|
CXCL8, F3, KDR, MET, SMAD3 |
2.09293 |
[BP] GO:0003013 |
None
|
ADORA1, ADRB1, EGFR, PTGS2, SRC, TEK |
2.09066 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.08876 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GRM5, IGF1R |
2.0848 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, CSNK2A1, CXCL8, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, MIF, PIM1, PTGS2, SMAD3, SRC |
2.07079 |
[BP] GO:1903524 |
None
|
ADRB1, EGFR, PTGS2, SLC1A1 |
2.07064 |
[BP] GO:0045765 |
regulation of angiogenesis
|
CXCL8, CYP1B1, ERBB2, F3, KDR, PTGS2, TEK |
2.07039 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, CACNA1C, KDR, SRC |
2.06659 |
[BP] GO:0052548 |
None
|
APP, CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.06349 |
[BP] GO:0050873 |
None
|
ADRB1, FABP4, PTGS2 |
2.04553 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, CYP1A1, CYP1B1, KDR, PRKCD, SRC |
2.04333 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, HSPA1A, MIF, MMP9, PTGS2, SRC |
2.03687 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, INSR, PRKCD, SRC |
2.01568 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.00909 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.00631 |
[BP] GO:0051336 |
regulation of hydrolase activity
|
ADRB1, APP, CSNK2A1, EGFR, ERBB2, F3, HSPA1A, MMP9, NUAK1, PRKCD, PTGS2, SMAD3, SRC, XDH |
2.00069 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX5, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EGFR, ERBB2, F3, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MAOA, MET, MMP2, NR3C2, PGR, PIM1, PRKCD, PTGES, PTGS1, PTGS2, SLC1A1, SMAD3, SRC, TEK, TYR |
6.50377 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, EGFR, ERBB2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, INSR, MET, PTGS2, SLC1A1, SRC, TEK |
5.86999 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRB1, APP, AXL, CA2, CA4, CA9, CACNA1C, DUSP3, EGFR, ERBB2, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PTGS2, SLC1A1, SRC, TEK |
5.23429 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRB1, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DUSP3, EGFR, ERBB2, F3, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B2, IGF1R, INSR, KDR, MAOA, MET, NR3C2, PTGES, PTGS1, PTGS2, SLC1A1, SRC, TEK, TYR |
5.16153 |
[CC] GO:0043235 |
receptor complex
|
APP, EGFR, ERBB2, GRIA2, GRIA4, GRIK5, GRM1, IGF1R, INSR, NR3C2, SMAD3 |
5.02014 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRB1, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, EGFR, ERBB2, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, MMP2, PIM1, PRKCD, SLC1A1, SMAD3, SRC, TEK |
4.98687 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRB1, APP, AXL, CA4, F3, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, TEK |
4.05446 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EGFR, GRIA2, HSD11B1, HSD17B2, NR3C2, PTGES, PTGS1, PTGS2 |
3.56647 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.47066 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.36078 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRB1, APP, AXL, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, TEK |
3.22321 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, ERBB2, TEK |
3.13619 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EGFR, FLT3, GRIA2, HSD11B1, HSD17B2, NR3C2, PTGES, PTGS1, PTGS2 |
3.13441 |
[CC] GO:0014069 |
None
|
ADORA1, CACNA1C, GRIK5, GRM1, GRM3, GRM5, SRC |
2.99689 |
[CC] GO:0099572 |
None
|
ADORA1, CACNA1C, GRIK5, GRM1, GRM3, GRM5, SRC |
2.99689 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, CACNA1C, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SRC |
2.91157 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APP, CA4, EGFR, ERBB2, HSPA1A, PRKCD, PTGES, SRC, TYR |
2.53861 |
[CC] GO:0043197 |
None
|
ADORA1, APP, GRIA2, GRIA4, GRM3 |
2.24061 |
[CC] GO:0044309 |
None
|
ADORA1, APP, GRIA2, GRIA4, GRM3 |
2.21171 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX5, APP, AR, AURKB, CA1, CA2, CA4, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GRIA2, GRIA4, GRIK5, HSD11B1, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MAOA, MIF, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PRKCD, PTGES, PTGS1, PTGS2, SMAD3, SRC, TYR, XDH |
2.19225 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.13911 |
[CC] GO:0045121 |
membrane raft
|
APP, EGFR, INSR, KDR, PTGS2, SRC, TEK |
2.0953 |
[CC] GO:0098857 |
membrane microdomain
|
APP, EGFR, INSR, KDR, PTGS2, SRC, TEK |
2.0848 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, AR, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, SMAD3, TYR, XDH |
11.4866 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.77745 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCD, PTGES, PTGS1, PTGS2, SLC1A1, SMAD3, SRC, TEK, TYR, XDH |
9.08016 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AR, AXL, EGFR, ERBB2, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, TEK |
9.02014 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, MET, TEK |
8.58686 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DUSP3, EGFR, ERBB2, F3, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PRKCD, PTGES, PTGS1, PTGS2, SRC, TEK, TYR, XDH |
8.45066 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
8.19035 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.09758 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRB1, AR, AXL, EGFR, ERBB2, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, TEK |
7.96102 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRB1, AR, AXL, EGFR, ERBB2, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, SMAD3, TEK |
7.80784 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.80784 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRB1, AR, AXL, EGFR, ERBB2, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, TEK |
7.73135 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2, SRC |
7.34093 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, MET, PRKCD, SRC, TEK |
7.15659 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2, SRC |
7.08315 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
6.93943 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B1, HSD17B1, HSD17B2, MAOA, PTGS1, PTGS2, TYR, XDH |
6.91725 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGS1, PTGS2, TYR |
6.75454 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, EGFR, ERBB2, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, TEK |
6.335 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, EGFR, ERBB2, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, TEK |
6.335 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.25387 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
6.01534 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, XDH |
5.52627 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.41125 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
5.3263 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PRKCD, SRC, TEK |
5.30888 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, INSR, KDR |
5.24445 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
5.19407 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, HSD17B1, IGF1R, INSR, NR3C1 |
5.08665 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD17B1, PTGES, PTGS1, PTGS2, SRC, XDH |
5.05762 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCD, PTGS1, PTGS2, SLC1A1, SMAD3, TYR, XDH |
4.94098 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, CA9, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARA, SMAD3 |
4.82209 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PIM1, PPARA, PRKCD, PTGS1, PTGS2, SLC1A1, SMAD3, TYR, XDH |
4.68442 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
4.47654 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
4.30567 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
3.88834 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, NR3C1, NR3C2, PGR, PPARA |
3.44433 |
[MF] GO:0019899 |
enzyme binding
|
ADRB1, APP, AR, AURKB, CYP1A1, CYP1A2, CYP2A6, DUSP3, EGFR, ERBB2, F3, GRM5, HSPA1A, MET, MIF, NR3C1, PGR, PPARA, PRKCD, PTGS2, SMAD3, SRC, TEK |
3.22321 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.15819 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
3.15819 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
ADRB1, EGFR, ERBB2, INSR, KDR, SMAD3 |
3.13619 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, INSR, PRKCD |
3.1086 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, ERBB2, IGF1R, INSR, KDR, TEK |
3.01197 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.93282 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.93282 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HSD11B1, HSD17B1, HSD17B2, XDH |
2.91818 |
[MF] GO:0005496 |
steroid binding
|
AR, HSD17B1, NR3C1, NR3C2, PGR |
2.79436 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, SMAD3, SRC |
2.70762 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.52571 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.47083 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.47083 |
[MF] GO:0031072 |
heat shock protein binding
|
ADORA1, CSNK2A1, HSPA1A, KDR, NR3C1 |
2.44035 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, SMAD3, SRC |
2.43668 |
[MF] GO:0030594 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
2.37984 |
[MF] GO:0043168 |
anion binding
|
APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCD, PTGES, SLC1A1, SRC, TEK, XDH |
2.29767 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.28525 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.28525 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD17B1, HSD17B2 |
2.22553 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.21171 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.09936 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCD, SLC1A1, SRC, TEK, XDH |
2.0953 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2 |
2.0848 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, CSNK2A1, EGFR, ERBB2, FLT3, GRIK5, IGF1R, KDR, MET, MIF, MMP9, PGR, PTGS2, SMAD3, TYR, XDH |
2.0848 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
2.06755 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2 |
2.00631 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.00631 |